{"@type":"Dataset","integmet_study":"MTBLS2014","mesh_chemical_id":["https://identifiers.org/mesh:D007737","https://identifiers.org/mesh:D014364","https://identifiers.org/mesh:D005947","https://identifiers.org/mesh:D000588","https://identifiers.org/mesh:D014280"],"mesh_chemical_pubtator_kw":["kynurenine","tryptophan","glucose","amines","triglycerides"],"mesh_disease_id":["https://identifiers.org/mesh:D003327","https://identifiers.org/mesh:D003920","https://identifiers.org/mesh:D000086382","https://identifiers.org/mesh:D007249","https://identifiers.org/mesh:D050171","https://identifiers.org/mesh:D017093","https://identifiers.org/mesh:D003324"],"mesh_disease_pubtator_kw":["coronary heart disease","diabetes","SARS-CoV-2 Infection","inflammation","severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","dyslipidemia","liver dysfunction","COVID-19","coronavirus disease 19","SARS-CoV-2 infection","coronary artery disease"],"mesh_gene_id":["https://identifiers.org/ncbigene:335"],"mesh_gene_pubtator_kw":["Apolipoprotein A1"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:9606"],"ncbi_taxonomy_pubtator_kw":["patients","human"],"source_id":"https://identifiers.org/metabolights:MTBLS2014","study_findings":"Systemic signature of SARS-CoV-2 includes liver dysfunction, dyslipidaemia, diabetes, coronary heart disease risk.","study_observation":"Quantitative plasma lipoprotein, metabolic, and amino acid data","study_summary":"Metabolic effects of SARS-CoV-2 on plasma analyzed.","study_title_original":"Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection"}